Analysis: South Africa secures good prices for TB medicines, with one exception

Spotlight
Oct. 23, 2019, 1:03 a.m.

An article published in Spotlight compares prices in recent South African Government tender for TB medicines versus global prices available via the Global Drug Facility. The article covers bedaquiline, delamanid, linezolid and rifapentine.

To read the full article, click here.